chr2-223995499-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001136528.2(SERPINE2):c.487+2616C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 152,106 control chromosomes in the GnomAD database, including 9,081 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.30 ( 9081 hom., cov: 33)
Consequence
SERPINE2
NM_001136528.2 intron
NM_001136528.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.37
Publications
4 publications found
Genes affected
SERPINE2 (HGNC:8951): (serpin family E member 2) This gene encodes a member of the serpin family of proteins, a group of proteins that inhibit serine proteases. Thrombin, urokinase, plasmin and trypsin are among the proteases that this family member can inhibit. This gene is a susceptibility gene for chronic obstructive pulmonary disease and for emphysema. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.566 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINE2 | NM_001136528.2 | c.487+2616C>T | intron_variant | Intron 3 of 8 | ENST00000409304.6 | NP_001130000.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.299 AC: 45369AN: 151988Hom.: 9058 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
45369
AN:
151988
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.299 AC: 45431AN: 152106Hom.: 9081 Cov.: 33 AF XY: 0.293 AC XY: 21784AN XY: 74354 show subpopulations
GnomAD4 genome
AF:
AC:
45431
AN:
152106
Hom.:
Cov.:
33
AF XY:
AC XY:
21784
AN XY:
74354
show subpopulations
African (AFR)
AF:
AC:
23737
AN:
41458
American (AMR)
AF:
AC:
3606
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
948
AN:
3472
East Asian (EAS)
AF:
AC:
723
AN:
5174
South Asian (SAS)
AF:
AC:
772
AN:
4824
European-Finnish (FIN)
AF:
AC:
1168
AN:
10586
Middle Eastern (MID)
AF:
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13551
AN:
67990
Other (OTH)
AF:
AC:
633
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1425
2849
4274
5698
7123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
503
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.